Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I'd like to know your prediction of the value of the shares of Gosy, after this news.
" We are negotiating a $1,200,000+ contract with a major defense contractor such that we may upgrade their ground combat vehicle to a high level of mobile autonomy. This is a non-trivial challenge because their off road 4x4 combat vehicle was not designed to be unmanned, driverless, or self driving. "
" The contractor graciously presented the merits of their off road 4X4 ground combat vehicle to be upgraded with GeckoSystems' proprietary AI SafePathâ„¢ technologies to "self-driving." Here, that capability would include automatically "going home" with little or no human control and/or intervention. "
" Due to the now executed PIA, the name of the contractor cannot be revealed until a contractual agreement is signed. "
"As a result of our recent meeting, we now believe that this first tier defense contractor shares our perception that they would enjoy dramatically increased sales since their upgraded product would be in extremely high demand by governments all over the world with an automatic 'go home' self driving capability....."
" On another, but related note, the company has reached mutually acceptable joint venture terms not only with Fubright Communications Co. Ltd., but also with their long time Japanese representatives, Mssrs. Katsuji Fujii and Hajime Yasumatsu. This joint venture's strategic focus is to enable use of GeckoSystems' GeckoNavâ„¢ self-guidance mobile robot software on SoftBank Robotics' personal robots to all Pepper users in Japan."
" GeckoSystems' Japanese joint venture, with Fubright and others, should see gross licensing revenues of:
$25,920,000 in 2016;
$176,670,000 in 2017; and
$409,230,000 in 2018.
GeckoSystems and their Japanese joint venture partners want to have their proprietary AI robotics software on every Pepper sold in the world. "
I agree, with a P / E to a prudent 10 possible P / E 20 can calculate a value between $ 0.06 and $ 0.12. The added value at this stage is the possible extension of the technology Gosy outside of Pepe.
I said:
Thanks Goku interesting article. But as you see there is no official statement of agreement with Geko. I believe that the actions of gosy take flight when released an official statement will be made clear where the gain from the company on the sale of each piece. They are probably still in agreement, or the CEO Spencer, thinking about our health, we want to preserve from heart attacks. Meanwhile, we love to dream, it costs nothing.
Of Course ! The share price will skyrocket if GekoNav will have a good application on Pepper. There will be gains for the company and its shareholders. But above you think that advertising will Gosy technology, with all the possible applications that can be made in various sectors. Cars, I think Nissan, wheelchairs, safety etc. Gekosystems may be the new Apple the years 2015. Those who buy now may find the way to $ 10 in two or three years.
Pepper sells 1,000 pieces a month, and we're just beginning, only in Japan. There is talk of royalty of $ 150-200 per Gosy for applying GekoNav. Personally I think it is an exaggerated figure, but if it were true the accounts are headaches. Just think of the sale of Pepper in the US and in Europe ........ the project is to make the robot as the home computer of the 80's .... go Gosy
I hope that the price is going up because of Gosy GekoNav will be mounted on Pepper, and not for the legal battles against Wallace. The potential and the future of Gosy be measured on sales of Pepper in Japan
I can only think that this is a mask in front of a problem that NRTIs do not want to do to know.
I refer to the fact, also happened to other companies, which NRTIs has miscalculated production. Made the discovery, or invested in a project, some companies realize late to have wrong accounts as "production costs", are not able to support them and it are dead. DNDN teaches.
The only solution to stake everything on what you can about the product with more profit margin and to hope.
If it is as you say, the error is correctable, just change CEOs and market philosophy. I'm very pissed off, I have a huge loss with NRTIs. Now i take a MS pill so I pull up.
I agree with you, but in addition to being sad I find it very disturbing. NRTIs that is still unknown to investors is safe, but that there is a lack of interest so strong shows a failure on the part of management. I think there are two cases: either the well-informed investors do not believe in the potential of NRTIs and consider this a failure product launches resulting in failure of the company, or the management of communication and the potential of NRTIs was completely wrong from the top of 'company. We Will See
yes, if you steps by others who follow him or have a conversation. However this man has a strange behavior.
sorry I left the message. Mr. Spencer has anonymous follower, and in any case I think it makes no sense for a president of the company that claims to inform shareholders via twitter, refuse, without reason, people who want to follow him. I never addressed questions or comments on twitter before being excluded. Now I can only follow through retwitt.
I'm not a animosus follow. To know
You're right, I too have been blocked by Spencer, for no reason. He is not interested in discussing on Twitter with shareholders. Not see his twitt? Google can not do this, Nissan can not do this, only Gosy can do it all !! But in the meantime 0.0031 in fall, and will reach 0,002 as a month ago. Exchanges to zero because no one believes in this technology. No News concrete agreements with companies encountered in Japan. I believe now that there are only opinions visionary and no practical way of making profits. In other words, the money shareholders Gosy, including my own, are money that serve to Spencer to play with his dreams. Money thrown to the wind, another year will pass and there will be another trip to Japan or Europe. TIMO
Goku good, I also tried to 0.0030 to buy. If someone sells me back to the 0.0022 I buy even better !! No wonder some of who buys low! I do not understand who sells at 0.0030 when the price is at 0.0050, with a few exchanges. I think so
but they were 8 million? you lightened !!
Thanks for your sharing, I think you made me change my mind. I do not understand how Spencer or those who work for him in Gecko can not find a partnership, or sale of this technology. $ 500,000 are selling 50 wheelchairs, in a potential of 200,000 people who use it and at least another 100,000 who are not unable to use it, but they would use. Remain of the view that an increase of the share capital in a well-defined plan for the production and sale of a product of this type, would be well received by the market. But you have to have the will to do so. It seems to me that Spencer has a desire and an interest other than that. But I hope that one day he can do it alone, maybe you saw after reaching an agreement with Nissan profitable Go Gosy
The problem in my opinion, is not money. If the project is economically viable, a capital increase aimed at conquering a market leader with a unique technology in the world, I do not think it would be a problem to find $ 500,000. I think the real problem is that this type of technology, for a wheelchair, does not bring a substantial advantage for the handicapped, but it can be an additional option maybe too expensive. And it is for this reason that it has not found and not finds no supporters. In fact to move, the person must still "drive" the wheelchair, and the possibility that the technology Geko can give, to avoid the obstacle in front of him, it only makes sense if the disabled person has a almost total disability. By restricting a large part of the market. It is different if the car moves by itself. Who use an electric wheelchair is able, somehow, to drive it. Mine are clearly just guesses, just to exchange views with other shareholders, but it is the only explanation I could give me to understand why you do not produce these wheelchairs. Even the efforts of Mr. Spencer oriented robots or application of GekoNav for future driverless car lead me to think about this. However Gosy strength, never below $ 0.0030.
If no one produces and sells a wheelchair like that of Geko, the question is: why not Geko produces and sells these wheelchairs?
i agree with you. Mr. Spencer has to give news soon. The good news is that the exchanges are very low, the smart people at this point have to take what they have bought. And 'possible agreement with Nissan very soon, and other arrangements are possible. 320000 shares traded against 8000000 two days ago. Smart people take at this time
Gosy technology has so many applications, that if part of a deal with Nissan, explodes in every field in a short time
Mr. Spencer has only to begin to monetize his work.
Crook thanks for your commitment and for sharing information. Regarding NRTIs hope, at this point, that the title falls to 0.0001, as PMCM that for over a month, every day, jumps of 100% more or less. As for the sales of other products, with Mr. James, I think only when I will see the published data. By
if speaking Mr. James
Does anyone know if there are reports of product sales inergetic specifically? I mean for every line of products distributed.
TRTC continues to fall, it is not a good sign. A title that was exchanged over $ 1. The news of the beginning of production of the CBD by NRTIs continue to lag. The fact that both exchanged NRTIs + or - 20% has no meaning with these volumes at these prices. From 0.33 to 0.015 in a few months ..... wow, it will be hard to recover, without press of extraordinary importance. Calm, patience, accumulate to mediate the average price, and hope that MR. James bait with ads that promised.
Crook, do you think that the only declaration to start production of CBD, could lead NRTI to the value of last year $ 0.15?
I'm beginning to think it's not just a problem of distribution but also of "goodness of the product." If people do not buy can also be because the product is not good. A good product, it always works. A product done wrong, you can do all the publicity you want, but do not sell. Fool people once .... not two. The most disturbing is that sales were down compared to December 2013 ..... it means: buy once .... maybe two, then just.
We, nbs ready to take off $ 17.00 per share. Fingers crossed for the data tomorrow, that will be good, even excellent. The premises are all. Go go nbs
I think that Mr. J could also let us know when you think there will be a product launch CBD. I can not understand why a distance of months now, there is still no exact date for the launch of the products. Now I'm months working there and an action plan will have it investigated. Personally, the thing that makes me suspicious of most. My fear is that this delay in the announcement may be because there is no force by NRTIs to meet the costs of production, distribution etc .... as is often the case for small industries. I am reminded of the case DNDN among the most egregious in recent years. I find it absurd that the value of this stock is 4 times lower than a year ago. It has no logic and it worries me. I continue to be inspired by reading on this website, by your words, and your optimism.
good week and
dear Robin my stocks do not take them at to 0.10 ..... but to 0,18 I can give you something
no matter how many you have depends on which media.
I agree with you. This exaltation of the managment team has to be proved with facts and numbers. It 'a fact that Mr.. James has signed a contract with Martha S that within a few months can not pay. It 'sa fact that so wrong accounts: either production costs or sales forecasts or the amount to be paid to MS. As has been enhanced in the past year sales increase of 7000% not referring to the fact that at that time the sales were those of a shop in the suburbs, we should admit that we need a total overhaul of the management of NRTI. Many products are new this is true, and the data of only one quarter tell little, if not the fact that with a gross margin of 24% sales should be at least 30 times to create a hope for a draw. Expect the data for the 2nd quarter. Now the biggest risk is that if the choices that have been made with MS are repeated with the CBD-based products can go with the butt on the ground between two years. Do not think that the world of cannabis is the prerogative of NRTIs and TRTC, there are dozens of companies that are moving. As a shareholder I would like to know in the figures, which are the steeps of sales to be achieved it has set NRTI before reinvesting.
I've already lost a lot of money on false promises, I'm sorry I do not trust and I warn. I hope to be wrong for you, but the $ 0.02 expected by me is getting closer.
One last thing, even aloe barbadensis and aloe arborescens, cure cancer, I'm sorry that these indications have appeared on cannabis. We're talking about a production of cannabis-based food supplements, or pharmaceuticals? in Europe it changes a lot, I do not know in America. But any drug product is sold only in pharmacies and in doctor's prescription, a product "made with ..." dietary supplement, it can be found in supermarkets and large distribution. Where is oriented NRTIs?
clear that I wanted to write $ 0.02 I made a mistake typing
We found Crookedneck. We know the real reason why Crook continues to support NRTIs despite everything. I understand now the continuous phone calls to Mr. James and his support in everything he does. The truth is that Crook expects the production of CBD for his back pain. ! More than gains on shares and accurate DD! It 'back pain the true source of information Crook ....! They've promised a supply of products for one year against CBD back pain!
I can recommend: Ruta graveolens 30C 5 pills 4 times a day in case of acute pain, when it passes 4 pills 2 times a day. Do not wait until the end of 2015 that the bait production CBD NRTIs for your back pain. You might never see her again.
Of course I'm kidding!
Meanwhile, expect the real sales data in the summer months, the months that matter, someone said in the past, so we see the "development" of the lines, and maybe change the feedback. As someone has already pointed out in the past, some choices of additional expenses to accommodate people within NRTIs, rather than focusing on products already on the market, and a must advertise with stronger choices, there were much appreciated secono my opinion . Now there is talk of production and distribution for 2015 but when? January or December?
This title will come down to 0.002 as in the past.
If not it will be better for everyone including myself. But I am very disappointed with this title, I've gone from being able to have a great gain to lose more than 50% for wanting to follow the instinct of those who said that the title would go to $ 1 by the end of 2014.
Let me be clear: BLAME AND 'MY ONLY and not to be a short.
Good luck to all.
hello to everyone, but those who say that all brands are growing? How can they be sure of that after what has happened? Also in 1q there must have been amazing data, but the reality was different. The data are clear, without a truly valid, advertised nationally, and with a production and sales 10 times higher than this, NRTIs will always be at a loss. Martha wants to be paid, including the search for new products and their launch costs and the old products do not break. I expect a pretty dilution, with a share value of $ 0.02 by the end of September. Personally, I am strongly at a loss, but I am convinced that will buy 0.01 $ 0008 by the end of the year to tie in March 2015 when it comes out some interesting data, or falsely interesting on the sale of supplements CBD. Expect the meantime, the summer data, and see how sales have grown, they are especially interested in those of the OM brand. What do you say? there will be an increase of 15,000% on this product that will splash the title?
I wish all the best to all of you who believe.
Crook Hello, I wonder though if you do not mind this continues to fall. Does not it seem strange that it continues to lose this way, I would have understood a long pause with prices stable at around 0.20. It 's true that trade in the last few weeks have been low under the meia 50 days, but I'm a bit worried. I am encouraged to read your optimism, and I've gone from 60k to 200k, but this week I will be very tense every day before the announcement. Also in October there had been some positive advances on sales, while at this time there is no data. I hope for me and for all of you who believe in NRTI, I made a good choice.
This title is crazy. There is not positive news that could make it go up. More good news coming out over the title loses value. You have to wait for the October data for AMR-001?
I wonder what is the acquisition of OmEssential products that go into internal competition with other supplements, but they will need to purchase costs, advertising and distribution. Maybe I'm wrong and these supplements are very popular in America, and they sell like crazy! But it was better to focus on the development of the distribution and sale of products just acquired?
thanks Crook response. I did not mean to say that you were the one to say that there will be some low sales in the first quarter of 2014. Mine was a question as a result of this decline in the price, I thought that one reason could be that of a rumor in market knowledge, a decline in demand products NRTIs. I wanted your opinion. Thanks for the clarification.
hello Croock how do you explain this decline? There are positive news, positive outlook, but the actions are undergoing a great decline. You can according to you that the sales data of the first trimenstre 2014 are disappointing? However for me today 20000 to 0,165
Seems possible acquisition of Neostem by Baxter?
A loss in 2013 of $ 5,451,912. Revenues for approximately $ 850,000. "Operating expenses are expected to decrease significantly as a percentage of revenues as revenues INCREASE, Given That most expenses are fixed or quasi-fixed in character." A company created to generate profits, NRTIs must increase sales by 800% to reach around breakeven. Many projects have just started in 2013 and is to be evaluated according to the TRTC in the time of product launch and sales prospects. It would be interesting to know what are the expectations from the CEO of this company's growth for 2014 and by when it imagines that he can get to generate profit. However, I added another 40k last week. Always ahead NRTIs!